Fig. 3 shows how ivermectin docks to SARS-CoV-2, which should be sufficient for an intelligent human to understand.
Ivermectin Docks to the SARS-CoV-2 Spike Receptor Binding Domain Attached to ACE2 (Icahn Medical School at Mt. Sinai, New York)
Ivermectin Docks to the SARS-CoV-2 Spike Receptor Binding Domain Attached to ACE2 (Icahn Medical School at Mt. Sinai, New York)
Ivermectin Docks to the SARS-CoV-2 Spike Receptor-binding Domain Attached to ACE2 - PubMed
The ivermectin docking we identified may interfere with the attachment of the spike to the human cell membrane. Clinical trials now underway should determine whether ivermectin is an effective treatment for SARS-Cov2 infection.
pubmed.ncbi.nlm.nih.gov